A study on cognitive decline with respect to metabolic syndrome and inflammation in elderly Indians

Neurology India

Volumn 63, Issue 4, 2015, Pages 537-541

  Ghosh, Anirban ^a   Biswas, Amlan Kanti ^a   Banerjee, Avinandan ^b  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

^b INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cognitive decline; elderly; high sensitivity C reactive protein; metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; AGING; ARTICLE; CHOLESTEROL BLOOD LEVEL; COGNITIVE DECLINE; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERGLYCEMIA; INDIAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; MODIFIED MINI MENTAL SCORE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; VERY ELDERLY;

EID: 84938899839     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.162037     Document Type: Article

References (23)

1. Rössner S. Obesity in the elderly - A future matter of concern? Obes Rev 2001;2:183-8
2. Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 2001;86:3574-8
3. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28
4. Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, et al. Vascular risk factors for incident Alzheimer disease and vascular dementia: The Cache County study. Alzheimer Dis Assoc Disord 2006;20:93-100
5. Yaffe K. Metabolic syndrome and cognitive disorders: Is the sum greater than its parts? Alzheimer Dis Assoc Disord 2007;21:167-71
6. Straub RH, Cutolo M, Zietz B, Schölmerich J. The process of ageing changes the interplay of the immune, endocrine and nervous systems. Mech Ageing Dev 2001;122:1591-611
7. Laaksonen DE, Niskanen L, Nyyssönen K, Punnonen K, Tuomainen TP, Valkonen VP, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 2004;47:1403-10
8. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - A new worldwide definition. Lancet 2005;366:1059-62
9. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-8
10. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004;292:2237-42
11. Yaffe K, Haan M, Blackwell T, Cherkasova E, Whitmer RA, West N. Metabolic syndrome and cognitive decline in elderly Latinos: Findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 2007;55:758-62
12. Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, et al. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007;30:2655-60
13. Zuliani G, Volpato S, Galvani M, Ble A, Bandinelli S, Corsi AM, et al. Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study. Atherosclerosis 2009;203:626-32
14. Yaffe K, Weston AL, Blackwell T, Krueger KA. The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol 2009;66:324-8
15. Launer LJ. Demonstrating the case that AD is a vascular disease: Epidemiologic evidence. Ageing Res Rev 2002;1:61-77
16. Jagust W, Harvey D, Mungas D, Haan M. Central obesity and the aging brain. Arch Neurol 2005;62:1545-8
17. Razay G, Vreugdenhil A, Wilcock G. The metabolic syndrome and Alzheimer disease. Arch Neurol 2007;64:93-6
18. Grundy SM. Inflammation, hypertension, and the metabolic syndrome. JAMA 2003;290:3000-2
19. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005;111:1448-54
20. Haffner SM. The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006;97:3A-11
21. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107:391-7
22. Windgassen EB, Funtowicz L, Lunsford TN, Harris LA, Mulvagh SL. C-reactive protein and high-sensitivity C-reactive protein: An update for clinicians. Postgrad Med 2011;123:114-9
23. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:S49-73